Douglas Robert Andrew's Form 4 filing
Resmed Inc (RMD) · filed Sep 16, 2022
- Accession no.
- 0001127602-22-022565
- Filed
- Sep 16, 2022
- Trade date
- Sep 15, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.00M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Douglas Robert AndrewCIK 0001352232 | Officer (President and COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2022 | ResMed Common Stock | MOption exerciseAcquired | +1,145 | $58.24 | +$66,684.8 | 22,709 | Direct | |
| Sep 15, 2022 | ResMed Common Stock | MOption exerciseAcquired | +16,888 | $58.24 | +$983,557.12 | 39,597 | Direct | |
| Sep 15, 2022 | ResMed Common Stock | SSaleDisposed | −11,189 | $232.51F2 | −$2,601,554.39 | 28,408 | Direct | |
| Sep 15, 2022 | ResMed Common Stock | SSaleDisposed | −6,000 | $232.38F2 | −$1,394,280 | 228,995 | Indirect | |
| Sep 15, 2022 | ResMed Common Stock | GGiftDisposed | −1,287 | $0.00 | $0 | 227,708 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2022 | ResMed Common Stock | MOption exerciseDisposed | −1,145 | $0.00 | $0 | 52,953 | Direct | |
| Sep 15, 2022 | ResMed Common Stock | MOption exerciseDisposed | −16,888 | $0.00 | $0 | 36,065 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $232.45 to $232.91. The price reported above reflects the weighted average sale price.
Referenced by the price of 2 transactions in Table I.